Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01938391 · ClinicalTrials.gov registry record · NA
Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT01938391 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 25 participants.
The verdict
NCT01938391, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
IVUS imaging will be utilized to assess performance of the Sponsor's Orbital Atherectomy System (OAS) followed by adjunctive balloon angioplasty (BA) in patients who have symptomatic peripheral artery disease (PAD) occurring in the Superficial Femoral Artery (SFA), Popliteal (POP), and/or Tibioperoneal Trunk (TPT).
Interventions
- DEVICE Stealth 360°® OAS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01938391
The ClinicalTrials.gov registry entry for NCT01938391 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stealth 360°® OAS is the first listed.
NCT01938391 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01938391 about?
NCT01938391 is a clinical study titled "Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal". IVUS imaging will be utilized to assess performance of the Sponsor's Orbital Atherectomy System (OAS) followed by adjunctive balloon angioplasty (BA) in patients who have symptomatic peripheral artery disease (PAD) occurring in the Superficial Femoral Artery (SFA), Popliteal (POP), and/or Tibioperon...
What is the current status of trial NCT01938391?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2013-01. Estimated completion is 2015-02.
What interventions are being tested in trial NCT01938391?
The interventions under investigation include: Stealth 360°® OAS (DEVICE).
Who is sponsoring clinical trial NCT01938391?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.